ExploreOutcomeRate of speech
Outcome

Rate of speech

Also known as: Rate of advanced imaging and specialty referrals over time Rate of car seat installation and use errors Rate of guideline-concordant testosterone prescribing Rate of inappropriate anticoagulation prescribing Rate of opioid re-prescribing and repeat overdose after nonfatal overdose Rate of speech Rate of speech (observable entity) Speech rate rate of accumulation of 16 DHHS-defined chronic conditions over median 36 years follow-up rate of fatal and nonfatal opioid-related overdose events across perinatal period rate of fatal and nonfatal opioid-related overdose events in postpartum period rate of opioid-related overdose events at 7-12 months postpartum
27 findings 4 papers 20 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (50)

None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
improvement

The rate of errors in car seat installation and use was 33% less in the intervention group than in the control group (error ratio of 0.67).

Effect: improvement; ratio of 0.67 (33% fewer errors)

Size: ratio of 0.67 (33% fewer errors)
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le
None
adverse

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Size: Only 5.4% had proper diagnosis; 16.5% had no testosterone le

Papers (4)